"A once-a-day pill for obesity could be a cheaper and more accessible weight-loss drug, after a study found the tablet can lead to significant reductions in body weight. More than 60 per cent of adults living in the UK are obese or overweight - a crisis which is costing the NHS about 107 billion a year. But almost one in five people taking the drug Orforglipron lost 20 per cent of their body weight after using it for a year and a half, researchers found."
"Although the weight loss seen in people taking the tablet is not as stark as that among patients taking Mounjaro, experts believe the tablet will be more accessible and convenient compared with weight-loss injections. Because this pill is easier to use and may be less expensive, it could allow more people access to effective weight-loss medications and make obesity treatment simpler and more convenient for patients everywhere, said Dr Stephen Lawrence, GP and associate clinical professor at the University of Warwick."
The Independent solicits donations to fund on-the-ground reporting across topics including reproductive rights, climate change, and Big Tech while keeping content free of paywalls for broad public access. A clinical study found a once-daily pill, Orforglipron, can produce significant reductions in body weight, with almost one in five users losing 20 percent of their weight after 18 months. Over 60 percent of UK adults are obese or overweight, imposing roughly A3107 billion annual costs on the NHS. Experts say the pill may be less potent than injectable options like Mounjaro but could be more accessible, convenient, and affordable for many patients.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]